Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Protein & Cell
|
October 8, 2017
IgG Fc engineering to modulate antibody effector functions
Xinhua Wang, Mary Mathieu, Randall J Brezski
Bioanalysis
|
October 17, 2018
Optimizing hybrid LC-MS/MS binding conditions is critical: impact of biotransformation on quantification of trastuzumab
Luna Liu, Keyang Xu, Jenny Li, et al.
The Journal of Biological Chemistry
|
November 3, 2004
Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling
Robert F Kelley, Klara Totpal, Stephanie H Lindstrom, et al.
The Journal of Biological Chemistry
|
December 2, 2017
Molecular characterization of human anti-hinge antibodies derived from single-cell cloning of normal human B cells
Tao Huang, Mary Mathieu, Sophia Lee, et al.
Journal of Molecular Biology
|
December 1, 2009
Multiple novel classes of APRIL-specific receptor-blocking peptides isolated by phage display
Nathaniel C Gordon, Samantha Lien, Jeremy Johnson, et al.
Molecular Pharmaceutics
|
June 1, 2016
Contribution of Antibody Hydrodynamic Size to Vitreal Clearance Revealed through Rabbit Studies Using a Species-Matched Fab
Whitney Shatz, Philip E Hass, Mary Mathieu, et al.
Scientific Reports
|
December 21, 2016
Structure of Crenezumab Complex with Aβ Shows Loss of β-Hairpin
Mark Ultsch, Bing Li, Till Maurer, et al.
Journal of Molecular Biology
|
March 6, 2013
Glycan shifting on hepatitis C virus (HCV) E2 glycoprotein is a mechanism for escape from broadly neutralizing antibodies
Homer Pantua, Jingyu Diao, Mark Ultsch, et al.
Mabs
|
December 15, 2018
Single cell-produced and in vitro-assembled anti-FcRH5/CD3 T-cell dependent bispecific antibodies have similar in vitro and in vivo properties
Ayse Meric Ovacik, Ji Li, Marie Lemper, et al.
Mabs
|
August 31, 2017
Protein engineering to increase the potential of a therapeutic antibody Fab for long-acting delivery to the eye
Devin Tesar, Jacob Luoma, Emily A Wyatt, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Protein & Cell
|
October 8, 2017
IgG Fc engineering to modulate antibody effector functions
Xinhua Wang, Mary Mathieu, Randall J Brezski
Bioanalysis
|
October 17, 2018
Optimizing hybrid LC-MS/MS binding conditions is critical: impact of biotransformation on quantification of trastuzumab
Luna Liu, Keyang Xu, Jenny Li, et al.
The Journal of Biological Chemistry
|
November 3, 2004
Receptor-selective mutants of apoptosis-inducing ligand 2/tumor necrosis factor-related apoptosis-inducing ligand reveal a greater contribution of death receptor (DR) 5 than DR4 to apoptosis signaling
Robert F Kelley, Klara Totpal, Stephanie H Lindstrom, et al.
The Journal of Biological Chemistry
|
December 2, 2017
Molecular characterization of human anti-hinge antibodies derived from single-cell cloning of normal human B cells
Tao Huang, Mary Mathieu, Sophia Lee, et al.
Journal of Molecular Biology
|
December 1, 2009
Multiple novel classes of APRIL-specific receptor-blocking peptides isolated by phage display
Nathaniel C Gordon, Samantha Lien, Jeremy Johnson, et al.
Molecular Pharmaceutics
|
June 1, 2016
Contribution of Antibody Hydrodynamic Size to Vitreal Clearance Revealed through Rabbit Studies Using a Species-Matched Fab
Whitney Shatz, Philip E Hass, Mary Mathieu, et al.
Scientific Reports
|
December 21, 2016
Structure of Crenezumab Complex with Aβ Shows Loss of β-Hairpin
Mark Ultsch, Bing Li, Till Maurer, et al.
Journal of Molecular Biology
|
March 6, 2013
Glycan shifting on hepatitis C virus (HCV) E2 glycoprotein is a mechanism for escape from broadly neutralizing antibodies
Homer Pantua, Jingyu Diao, Mark Ultsch, et al.
Mabs
|
December 15, 2018
Single cell-produced and in vitro-assembled anti-FcRH5/CD3 T-cell dependent bispecific antibodies have similar in vitro and in vivo properties
Ayse Meric Ovacik, Ji Li, Marie Lemper, et al.
Mabs
|
August 31, 2017
Protein engineering to increase the potential of a therapeutic antibody Fab for long-acting delivery to the eye
Devin Tesar, Jacob Luoma, Emily A Wyatt, et al.
Page
of 2